oa SA Pharmaceutical Journal - Product news



Extracted from text ... 49 SA Pharmaceutical Journal - October 2006 PRODUCT NEWS Boehringer-Ingelheim is proud to announce the launch of the new ATROVENT(r) 20 HFA metered dose inhaler which will replace the existing ATROVENT(r) 40 inhaler once stocks are depleted. The availability of ATROVENT(r) 20 HFA is in line with Boehringer-Ingelheim's commitment to provide effective and affordable alternatives to CFC-containing inhalers. ATROVENT(r) 20 HFA is indicated for the relief of symptoms associated with asthma and COPD. Each 20 1/4l metered dose (puff) contains 0, 021 mg ipratropium bromide and it will be necessary to adjust the patient's dosage accordingly. Patients using ATROVENT(r) 20 ..


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error